Characteristics | Before matching | After matching | |||
---|---|---|---|---|---|
Linagliptin (n = 401) | Control (n = 17,227) | P | Control (n = 802) | P | |
Non-DM medication | |||||
 Aspirin | 341 (85.0) | 14,549 (84.5) | .750 | 682 (85.0) | 1.000 |
 Clopidogrel | 206 (51.4) | 6696 (38.9) | < .001 | 393 (49.0) | .439 |
 Warfarin | 24 (6.0) | 1096 (6.4) | .760 | 47 (5.9) | .931 |
 NOAC | 4 (1.0) | 197 (1.1) | .785 | 8 (1.0) | 1.000 |
 ACEI/ARB | 275 (68.6) | 10,829 (62.9) | .019 | 548 (68.3) | .930 |
 β-blocker | 208 (51.9) | 7388 (42.9) | < .001 | 421 (52.5) | .838 |
 CCB | 209 (52.1) | 8963 (52.0) | .971 | 431 (53.7) | .595 |
 Digoxin | 20 (5.0) | 957 (5.6) | .623 | 45 (5.6) | .652 |
 Statin | 218 (54.4) | 8048 (46.7) | .002 | 443 (55.2) | .774 |
 NSAID | 99 (24.7) | 4321 (25.1) | .857 | 208 (25.9) | .640 |
 Cox-2 inhibitor | 28 (7.0) | 1493 (8.7) | .235 | 54 (6.7) | .871 |
 Diuretic | 116 (28.9) | 3528 (20.5) | < .001 | 217 (27.1) | .494 |
 Spironolactone | 35 (8.7) | 1355 (7.9) | .526 | 65 (8.1) | .712 |
 Fibrate | 32 (8.0) | 1242 (7.2) | .556 | 72 (9.0) | .562 |
DM medication | |||||
 Biguanide | 156 (38.9) | 8177 (47.5) | .001 | 331 (41.3) | .430 |
 Sulfonylurea | 204 (50.9) | 6864 (39.8) | < .001 | 445 (55.5) | .130 |
 Thiazolidinedione | 27 (6.7) | 869 (5.0) | .128 | 47 (5.9) | .553 |
 Alpha-glucosidase inhibitor | 81 (20.2) | 2037 (11.8) | < .001 | 165 (20.6) | .879 |
 Non-SU insulin secretagogue (Glinide) | 93 (23.2) | 2397 (13.9) | < .001 | 164 (20.4) | .274 |
 Insulin | 244 (60.8) | 7807 (45.3) | < .001 | 484 (60.3) | .868 |